Test to Determine Best Hepatitis C Treatment

French scientists have identified biomarkers that predict responses to Hepatitis C therapy and expect to commercialize a prognostic test sometime this year, according to a release. Researchers at Inserm and Institut Pasteur, writing in The Journal of Clinical Investigation, say they have demonstrated that the plasma levels of the protein IP-10 predict the efficacy of treatment with pegylated-interferon and ribavirin.

The researchers say a new test will help inform physicians of the chances that patients will respond to standard treatment or if instead they will require new therapeutic cocktails such as prote